PhaseBio: Cash-strapped PhaseBio sued by drug development partner in dispute over experimental therapy
The California-based development partner wants to take over the development of PhaseBio's lead new drug candidate.
Read full article »
PhaseBio is a biopharmaceutical firm that researches and develops novel therapeutics for the treatment of orphan diseases.
Read more